IgA nephropathy in a patient with ulcerative colitis, Graves disease and positive myeloperoxidase ANCA

Clinical Nephrology

Volumn 77, Issue 2, 2012, Pages 146-150

  Ku, Elaine ^a   Ananthapanyasut, Wanwarat ^a   Campese, Vito M ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Anca; Graves disease; Iga nephropathy; Methimazole; Ulcerative colitis

Indexed keywords

ALBUMIN; BICARBONATE; CALCIUM; CREATININE; NEUTROPHIL CYTOPLASMIC ANTIBODY; POTASSIUM; SODIUM; PEROXIDASE;

ADULT; ANEMIA; ANOREXIA; ARTICLE; BLURRED VISION; CASE REPORT; DIARRHEA; EXOPHTHALMOS; FEMALE; GRAVES DISEASE; HEMATURIA; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; MEAN CORPUSCULAR VOLUME; PHYSICAL EXAMINATION; PROTEINURIA; ULCERATIVE COLITIS; URINALYSIS; WEIGHT REDUCTION;

ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; COLITIS, ULCERATIVE; FEMALE; GLOMERULONEPHRITIS, IGA; GRAVES DISEASE; HUMANS; PEROXIDASE;

EID: 84859505708     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN106770     Document Type: Article

References (23)

1. Monsén U, Sorstad J, Hellers G, Johansson C. Extracolonic diagnoses in ulcerative colitis: an epidemiological study. Am J Gastroenterol. 1990; 85: 711-716.
2. Powell FC, Schroeter AL, Su WP, Perry HO. Pyoderma gangrenosum: a review of 86 patients. Q J Med. 1985; 55: 173-186.
3. Inokuchi T, Moriwaki Y, Takahashi S, Tsutsumi Z, Ka T, Yamamoto T. Autoimmune thyroid disease (Graves' disease and hashimoto's thyroiditis) in two patients with Crohn's disease: case reports and literature review. Intern Med. 2005; 44: 303-306.
4. Bonapace ES, Srinivasan R. Simultaneous occurrence of inflammatory bowel disease and thyroid disease. Am J Gastroenterol. 2001; 96: 1925-1926.
5. Oudkerk Pool M, Ellerbroek PM, Ridwan BU, Goldschmeding R, von Blomberg BM, Peña AS, Dolman KM, Bril H, Dekker W, Nauta JJ, et al. Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment. Gut. 1993; 34: 46-50.
6. Ellerbroek PM, Oudkerk Pool M, Ridwan BU, Dolman KM, von Blomberg BM, von Dem Borne AE, Meuwissen SG, Goldschmeding R. Neutrophil cytoplasmic antibodies (p-ANCA) in ulcerative colitis. J Clin Pathol. 1994; 47: 257-262.
7. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol. 2003; 3: 521-533.
8. Barratt J, Feehally J. Treatment of IgA nephropathy. Kidney Int. 2006; 69: 1934-1938.
9. Mestecky J. Immunobiology of IgA. Am J Kidney Dis. 1988; 12: 378-383.
10. Roccatello D, Picciotto G, Torchio M, Ropolo R, Ferro M, Franceschini R, Quattrocchio G, Ca Cace G, Coppo R, Sena LM, et al. Removal systems of immunoglobulin A and immunoglobulin A containing complexes in IgA nephropathy and cirrhosis patients. The role of asialoglycoprotein receptors. Lab Invest. 1993; 69: 714-723.
11. Layward L, Finnemore AM, Allen AC, Harper SJ, Feehally J. Systemic and mucosal IgA responses to systemic antigen challenge in IgA nephropathy. Clin Immunol Immunopathol. 1993; 69: 306-313.
12. Donadio JV, Grande JP. IgA nephropathy. N Engl J Med. 2002; 347: 738-748.
13. Barratt J, Eitner F, Feehally J, Floege J. Immune complex formation in IgA nephropathy: a case of the 'right' antibodies in the 'wrong' place at the 'wrong' time? Nephrol Dial Transplant. 2009; 24: 3620-3623.
14. Beerman I, Novak J, Wyatt RJ, Julian BA, Gharavi AG. The genetics of IgA nephropathy. Nat Clin Pract Nephrol. 2007; 3: 325-338.
15. Pouria S, Barratt J. Secondary IgA nephropathy. Semin Nephrol. 2008; 28: 27-37.
16. Trimarchi HM, Iotti A, Iotti R, Freixas EA, Peters R. Immunoglobulin A nephropathy and ulcerative colitis. A focus on their pathogenesis. Am J Nephrol. 2001; 21: 400-405.
17. Haas M, Jafri J, Bartosh SM, Karp SL, Adler SG, Meehan SM. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits. Am J Kidney Dis. 2000; 36: 709-718.
18. Gunton JE, Stiel J, Clifton-Bligh P, Wilmshurst E, McElduff A. Prevalence of positive anti-neutrophil cytoplasmic antibody (ANCA) in patients receiving anti-thyroid medication. Eur J Endocrinol. 2000; 142: 587.
19. Gumà M, Salinas I, Reverter JL, Roca J, Valls-Roc M, Juan M, Olivé A. Frequency of antineutrophil cytoplasmic antibody in Graves' disease patients treated with methimazole. J Clin Endocrinol Metab. 2003; 88: 2141-2146.
20. Wing SS, Fantus IG. Adverse immunologic effects of antithyroid drugs. CMAJ. 1987; 136: 121-127.
21. Livideanu C, Lipsker D, Paul C, Juillard J, Schubert B. Pyoderma gangrenosum as initial manifestation of Graves' disease. Clin Exp Dermatol. 2006; 31: 659-661.
22. Winters MJ, Hurley RM, Lirenman DS. ANCApositive glomerulonephritis and IgA nephropathy in a patient on propylthiouracil. Pediatr Nephrol. 2002; 17: 257-260.
23. Peeters AJ, van den Wall Bake AW, Daha MR, Breeveld FC. Inflammatory bowel disease and ankylosing spondylitis associated with cutaneous vasculitis, glomerulonephritis, and circulating IgA immune complexes. Ann Rheum Dis. 1990; 49: 638-640.